INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 223 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,140,000 | -19.7% | 159,284 | +4.0% | 0.01% | -12.5% |
Q2 2021 | $1,420,000 | +3.4% | 153,222 | +3.6% | 0.01% | -11.1% |
Q1 2021 | $1,373,000 | +0.7% | 147,950 | -4.0% | 0.01% | 0.0% |
Q4 2020 | $1,364,000 | -11.0% | 154,113 | +16.6% | 0.01% | -18.2% |
Q3 2020 | $1,533,000 | -28.9% | 132,147 | -77.1% | 0.01% | -38.9% |
Q1 2019 | $2,156,000 | -6.7% | 578,013 | +0.1% | 0.02% | -10.0% |
Q4 2018 | $2,311,000 | -17.7% | 577,634 | +14.4% | 0.02% | +11.1% |
Q3 2018 | $2,807,000 | +42.0% | 504,818 | +0.1% | 0.02% | +38.5% |
Q2 2018 | $1,977,000 | -16.8% | 504,426 | -0.1% | 0.01% | +116.7% |
Q1 2018 | $2,375,000 | -2.2% | 504,709 | +90.8% | 0.01% | 0.0% |
Q4 2014 | $2,428,000 | +8.5% | 264,470 | +16.4% | 0.01% | +20.0% |
Q3 2014 | $2,238,000 | – | 227,185 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STONERIDGE INVESTMENT PARTNERS LLC | 521,775 | $4,258,000 | 0.53% |
Round Table Services, LLC | 73,500 | $600,000 | 0.47% |
Cheyne Capital Management (UK) LLP | 160,000 | $1,305,000 | 0.42% |
SABBY MANAGEMENT, LLC | 906,000 | $7,393,000 | 0.27% |
Bellevue Asset Management AG | 200,000 | $1,632,000 | 0.23% |
GLOBEFLEX CAPITAL L P | 122,000 | $996,000 | 0.18% |
WASATCH ADVISORS LP | 1,959,114 | $15,986,000 | 0.17% |
EMERALD ADVISERS, LLC | 288,486 | $2,354,000 | 0.11% |
Rotella Capital Management, Inc. | 13,840 | $113,000 | 0.09% |
Catalyst Capital Advisors LLC | 65,000 | $530,000 | 0.06% |